Medical Hypotheses
Volume 66, Issue 2 , Pages 234-246, 2006

A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

  • Ethan Russo

      Affiliations

    • GW Pharmaceuticals, Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, UK
    • University of Washington School of Medicine, Seattle, WA, USA
    • University of Montana Department of Pharmaceutical Sciences, MT, USA
    • Corresponding Author InformationCorresponding author. Present address. 2235 Wylie Avenue, Missoula, MT 59802, USA. Tel.: +1 406 542 0151; fax: +1 406 542 0158.
    • ,
  • Geoffrey W. Guy

      Affiliations

    • GW Pharmaceuticals, Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ, UK

Received 15 August 2005; accepted 18 August 2005. published online 04 October 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(05)00431-7

doi:10.1016/j.mehy.2005.08.026

Medical Hypotheses
Volume 66, Issue 2 , Pages 234-246, 2006

Article Tools

* Image Usage & Resolution